Dopamine via G-protein-coupled receptor kinase 4 (GRK-4) regulates sodium (Na) balance in the proximal tubule of the kidney. Single-nucleotide polymorphisms of GRK-4 have been linked to impaired natriuresis and salt-sensitive hypertension. The purpose of this report was to determine the effect of GRK-4 gene polymorphisms on the blood pressure (BP) responses to dietary intervention. Black subjects aged 50-75 years with mildto-moderate hypertension were randomised to an 8-week dietary intervention (n ¼ 40) or standard diet (n ¼ 40). BP was measured at baseline and at 8 weeks using 24-h ambulatory BP. All subjects underwent DNA analysis for the R65L and A142V polymorphisms. Data were analysed using generalised linear models. For the whole group, between-diet differences in mean 24-h ambulatory systolic BP was À4.53 mm Hg (95% confidence interval À9.05 to À0.01, P ¼ 0.05). In the intervention arm, the combined CC and CT group of the A142V showed a significant reduction in both systolic and diastolic ambulatory BP (À10 mm Hg, P ¼ 0.023 and À6.5 mm Hg, P ¼ 0.01, respectively), whereas the TT group demonstrated no reduction. Similarly, the combined GG and GT groups of the R65L showed a significant reduction in ambulatory BP (À10.6 mm Hg for systolic, P ¼ 0.004 and 5.8 mm Hg for diastolic, P ¼ 0.006). There was no response in the TT group. GRK-4 polymorphisms predict BP response to dietary modification in Black subjects with mild-to-moderate hypertension. These data may provide at least one among a range of clinical tools to target selected hypertensives to dietary intervention.
Introduction
In South Africa, the prevalence of hypertension in the adult Black population is 24.4%. 1 Diagnosis and management of the condition in this group is particularly poor, especially modification of lifestyle. 2 The average daily salt intake of 7.8 g in this group exceeds the recommended maximum of 6 g day À1 (ref.
3). Average potassium (K) intake is low (between 50 and 60 mmol day À1 ) due to an inadequate intake of fruit, vegetable and dairy food, 4, 5 with the result that the sodium/potassium ratio falls far below that recommended by the WHO. 6 The DASH trial provided evidence that a dietary pattern that is rich in fruit, vegetables, and low-fat dairy products and sodium (Na) can reduce blood pressure (BP) significantly, especially in African Americans. 7 We have previously shown in a randomised, double-blind, controlled clinical trial that a culturally appropriate dietary modification of Na, K, Ca and Mg intake resulted in a significant reduction in ambulatory BP in indigenous Africans (Blacks) from South Africa with mild-to-moderate essential hypertension. 8 Essential hypertension is a complex disease characterised by a sustained elevation in BP with no known underlying medical or biological cause. The heritability of hypertension is thought to range from 30 to 60%. 9, 10 In a subset of patients there appears to be a greater rise or fall in BP related to increased or decreased Na in the diet, respectively, and this is termed as salt-sensitive hypertension. It is more prevalent in people of indigenous African origin; for example, 73% of African-American hypertensive patients, compared with 51% of the total hypertensive population and 26% of normotensive individuals, have been identified as being salt sensitive. 11, 12 In a study from South Africa, suppressed plasma renin activity (an indirect index of salt sensitivity) was significantly lower in both normotensive and hypertensive Blacks compared with Caucasians despite comparable sodium intake. 13 This was particularly evident in normotensives, where 14.9% of Caucasians and 70% of Blacks had a suppressed plasma renin activity o1.1 ng ml À1 h À1 . An important regulator of Na balance is dopamine, which is locally generated in the kidney. Under the conditions of Na excess, dopamine acts on the renal tubular cells to promote natriuresis. Renal dopamine is responsible for over 50% of the incremental Na excretion in response to increased Na intake.
14 G-protein-coupled receptor kinase 4 (GRK-4) uncouples D 1 receptor from its G-protein effector complex to protect the cell from repeated agonist exposure. In hypertension there appears to be constitutive desensitisation of the renal D 1 receptor.
14 Expression of three gene variants of the GRK-4 (R65L, A142V, and A486V) in cell lines of rats results in impaired Na excretion and elevation in BP and this is rectified by prevention of GRK-4 expression. 15 Of the gene variants A142V showed the maximum activity. In a Japanese study, the GRK4-A142V single-nucleotide polymorphism (SNP) was 78.4% predictive of low renin hypertension; with the combination of all three variants the predictive value rose to 94.4%. 16 The R65L aminoacid substitution was also associated with impaired stress-induced sodium excretion in Black normotensive men. 17 In a preliminary unpublished study in South Africans, we found the variant T allele of the A142V SNP to be significantly more frequent in Blacks compared with Whites (73 vs 23%, respectively) (Rayner et al., unpublished data). With this in mind we decided to study the effects of the A142V and R65L SNPs on the BP response to dietary intervention in the study performed previously.
Methods

Participants and outcome
The methods for this study have been published in detail elsewhere. 8 Briefly, Black residents of a peri-urban Cape Town township, aged 50-75 years, with drug-treated mild-to-moderate hypertension (systolic BP p160 mm Hg and diastolic BP p95 mm Hg) were eligible for the study. The intervention was an 8-week provision of six food items with a modified cation content (salt replacement (SOLO), bread, margarine, stock cubes, soup mix and a flavour enhancer) and 500 ml day À1 of maas (fermented milk). The control diet provided the same quantities of the targeted foods, but of standard commercial composition, and 500 ml day À1 of artificially sweetened cool drink. Based on laboratorydetermined chemical food analyses, compared with control foods, the intervention foods were planned to provide 41% less Na (100.3 vs 170.3 mmol day Primary outcome measures were the differences from baseline in 24-h ambulatory systolic and diastolic BP measured during the final week of the intervention using an Oscar 2 (SunTech Medical, Morrisville, NC, USA) Ambulatory BP Monitor in the control and intervention arm in relation to the A142V and R65L SNPs of the GRK-4 gene.
DNA analysis
Blood was taken at baseline for DNA analysis of GRK-4 SNPs (A142V and R65L). DNA was isolated from the peripheral blood leukocytes. The presence of the GRK-4 exon 5 (rs2014323) A142V SNP was confirmed by direct sequencing. The forward and reverse primers were 5 0 -CCTCCAGATGTTGTGACA-3 0 and 5 0 -GTGCCTCGTGTGTAC-ATGG-3 0 , respectively. PCR produced a DNA fragment of 283 bp. Sequencing analysis was done and Chromas software (Brisbane, Queensland, Australia) was used for SNP analysis.
A restriction enzyme assay was used to detect the GRK-4 exon 3 (rs2960306) R65L SNP. The forward and reverse primers were 5 0 -AGTGAGCGGAGATTG TACCG-3 0 and 5 0 -TGAGACGGAGTCTTGCTGTG-3 0 , respectively, and a 670-bp fragment was produced by PCR. BsaHI restriction endonuclease (New England Biolabs, Ipswich, MA, USA) was used to cut this fragment. The R65L mutation destroys the restriction site of the BsaHI enzyme. Thus, the TT homozygote will produce a 670-bp uncut fragment, the GG homozygote 411 and 259-bp fragments, and the heterozygote all three fragments.
Statistical analysis
As the BP were measured over time, the study groups and genetic marker groups were analysed using repeated-measures analysis. This was done using generalised linear models with an identity GRK-4 polymorphisms predict blood pressure response B Rayner et al link function and clustering indicator for each participant to enable the standard errors of the estimates to be adjusted for the repeated measurements. The regression models included interaction terms of time and genetic marker group as this was the main inference of the study.
Results
The control and intervention groups were wellmatched at baseline except for an average 5.5 kg higher body weight in the intervention group ( Table 1 ). In the overall study there was a significant decline in BP in the intervention group. The intervention effect, estimated as the contrast of the within-diet group changes in BP from baseline to post-intervention, was a significant reduction in 6.2 mm Hg (95% confidence interval (CI) 0.9-11.4, P ¼ 0.021) for systolic BP. The largest intervention effect in 24-h BP was for wake systolic BP, with a reduction of 5.12 mm Hg (95% CI 0.4-9.9, P ¼ 0.036). For wake diastolic BP, a reduction of 2.7 mm Hg (95% CI À0.2 to À5.6, P ¼ 0.072) was found. 8 Based on 24-h urine estimations the difference in mean urinary Na, K, Mg and Ca between the control and intervention groups, taking an average of measurements at 4 and 8 weeks, was À8.7, þ 24.6, þ 0.68 and À0.5 mmol per 24 h, respectively.
The distribution of A142V and R65L polymorphisms is shown in Table 2 . We were unable to genotype two patients in the control group for A142V SNPs, and five patients and two patients in the control and intervention groups, respectively, for R65L SNPs due to technical reasons. Because the numbers of CC and GG genotypes were very small (but it is in line with genotype frequency in the Black patients previously reported), the CC and CT, and the GG and GT groups were combined for statistical analysis. The baseline ambulatory BP characteristics according to genotype are shown in Table 3 . There were no significant differences between the groups, except that in the CC/CT group the 24-h mean diastolic BP was significantly higher in the intervention group. The mean 24-h urine Na and K in the CC/CT and TT groups of the A142V was 148.5 vs 165 mmol day À1 , P ¼ 0.34, and 45.9 vs 50.2 mmol day À1 , P ¼ 0.28, and in the GG/GT and TT groups 149.6 vs 177.9 mmol day À1 , P ¼ 0.14, and 48.2 vs 51.7, P ¼ 0.49, respectively.
In the control group 24-h mean systolic and diastolic BP responses were identical between the R65L and A142V SNPs of the GRK-4 gene. (Table 4) In the intervention arm the combined CC and CT group of the A142V showed a significant reduction in both systolic and diastolic BP (À10 mm Hg, P ¼ 0.023 and À6.5 mm Hg, P ¼ 0.01, respectively) whereas the TT group demonstrated no reduction in BP (Table 4) . Similarly, the combined GG and GT groups of the R65L showed a significant reduction in BP (À10.6 mm Hg for systolic, P ¼ 0.004 and À5.8 mm Hg for diastolic, P ¼ 0.006). There was no response in the TT group, ( Table 4) . The results were statistically significant compared with the control arm for the R65L group (P ¼ 0.024 and P ¼ 0.41 for the systolic and diastolic BP, respectively). 
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Discussion
In this controlled study, simply by changing the cation content of five commonly eaten foods, providing a salt replacement, together with the daily addition of a fermented milk drink, the effects of the DASH diet 7 could be achieved in Black South Africans treated hypertensive subjects who habitually consume a high salt intake in the presence of a low intake of fruit, vegetables and dairy products. We achieved similar BP reduction in diet and control groups as those reported in participants in the high-Na arm of the DASH-Sodium study. 7 In this study the dietary response was analysed according to GRK-4 SNPs. The main finding of the study was that subjects with the GG/GT genotype of the R56L responded to dietary intervention and there was no response to dietary intervention in the TT group. Similar findings were found in the combined CC/CT vs TT genes of the A142V, but were less statistically robust. As anticipated, there was no influence on BP in the control group.
The strength of the study is that BP responses were based on 24 ambulatory monitoring, using an instrument that has been validated and endorsed by the British Hypertension Association as being reliable for use in clinical trials. 18 In addition the food supplied to the subjects adherence to the study protocol was good and this was confirmed by 24-h urine collections. The limitations of the study were the small numbers especially in the CC and GG groups. The small numbers did not allow us to investigate gene-gene interactions between the R65L and A142V. In addition the baseline BP levels were higher in the CC/CT genotypes perhaps exaggerating BP responses. However, this was not the case for R65L group.
This study provides further confirmation of the importance of GRK-4 in Na balance and BP as described previously by others in both animals and humans. 15 As dietary interventions in hypertensive patients are notoriously difficult to implement, in the long term this study provides evidence for a targeted approach. It suggests that patients with GG and GT genotypes of the R65L polymorphisms will be most likely to respond to the dietary intervention described. However, this strategy will need to be tested in controlled clinical trials of a longer duration to assess the overall outcomes.
It is important to note that this is not strictly a dietary Na restriction study and involved supplementation of the diet with beneficial cations. Based on urinary excretion of electrolytes the difference in Na restriction between the control and intervention group was relatively modest (À8.7 mmol day À1 ), but there was a 24.6 mmol day À1 increase in K intake. However, as elegantly outlined by Androgué and Madias, increased K in the diet offsets the adverse effects of high Na, thus explaining the significant reductions in BP seen in this study. 19 We tentatively propose that GRK-4 polymorphisms in the proximal tubule of the kidney alter Na excretion in response to high Na/low K diet, and thus determines the BP response to dietary intervention. As these polymorphisms (TT of the A142C and TT of the R65L) are more common in people of African descent it may underpin their susceptibility to a high salt intake.
Our study provides an interesting paradox that challenges conventional understanding of the salt-sensitive phenotype/genotype. Current dogma defines salt sensitivity as a greater rise in BP in response to Na loading as well as a greater reduction in response to Na restriction. It is also hypothesised that the underlying susceptibility to salt sensitivity is due to an intrinsically increased ability of the kidneys to retain Na or reduced ability to excrete Na in response to Na scarcity and excess, respectively. Thus, it would have been predicted that both the TT genotypes of the A142V and R65L would have shown the best response to Na restriction in our study as both these genotypes impair the ability of the kidney to excrete Na in animal models. 15 In fact our study showed the opposite effect with the combined CC/CT and GG/GT groups having the best response.
However, if we consider the issue from a common sense perspective, subjects with reduced ability to retain Na in response to restriction are likely to have the best BP response to modest Na restriction and the subjects with enhanced ability to retain Na may resist the effects of Na restriction. However, we could speculate that the CT/TT and GT/GT may need an even more intense restriction of Na to achieve BP responses because of their enhanced ability to retain Na.
In conclusion we found that the combined CC/CT and GG/GT, but not TT genotypes of R65L had a significant BP response to dietary intervention that included Na restriction in the presence of an increased K, Mg and Ca intake. These intriguing observations require confirmation in a larger study before contributing to the discussion of using a targeted approach to dietary intervention in hypertensives.
